BKM Wealth Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
Other funds holding AZN
BKM Wealth Management's AZN Position: Q3 2026 in Review
BKM Wealth Management increased its AstraZeneca (AZN) stake by 5.3% in Q3 2026, buying an estimated $27.3K and bringing the position to 3,234 shares worth $522K. The position accounts for 0.17% of the portfolio, ranked #105.
BKM Wealth Management first reported a position in AZN in Q4 2023 and has held it in 12 quarters since. The position peaked at $582K in Q2 2026. 1,444 funds tracked by Wall St. Rank hold AZN as of Q3 2026.
- BKM Wealth Management held 3,234 shares of AstraZeneca worth $522K as of Q3 2026.
- BKM Wealth Management bought 164 AstraZeneca shares in Q3 2026, an estimated $27.3K.
- AstraZeneca made up 0.17% of BKM Wealth Management's portfolio in Q3 2026, its #105 holding.
- BKM Wealth Management first reported a position in AstraZeneca in Q4 2023 and has held it in 12 quarters since.
- BKM Wealth Management's AstraZeneca position peaked at $582K in Q2 2026.
- 1,444 funds tracked by Wall St. Rank held AstraZeneca as of Q3 2026.
Based on BKM Wealth Management's 13F filing for Q3 2026, filed 22 Oct 2026.